Wantstats
Company ProfilePremium

SECOND SIGHT

Company Profile Analysis

Book DemoRegister Your Interest
ESOMAR 23 Corporate BadgeISO Certifications Badge
SECOND SIGHT - Healthcare showcase

Year Founded & Workforce

1998

123 Employees

Industry

Healthcare

Services

Artificial Retina
S

SECOND SIGHT Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

SECOND SIGHT Overview

Company Headquarters: California, US

Founded: 1998

Workforce: ~123+

Company Working: Second Sight develops, manufactures, and markets prosthetic devices used as a treatment for blind individuals. Its principal office is in California, US. The company also has an office in Switzerland, which manages clinical and commercial operations in Europe, Asia, and the Middle East. It sells its products across Europe, Saudi Arabia, the US, Canada, Turkey, Iran, Taiwan, South Korea, Russia, and Singapore.

Strategy

Second Sight focuses on the development of neurostimulation technologies to enhance the lives of blind individuals while supporting its current customers by catering to their needs. The company also focuses on acquiring additional businesses and forming strategic alliances to expand its business in the market.

Company Snapshot

$4M

Revenue

123

Employees

1998

Founded

California, US

Headquarters

SWOT Analysis

Strengths

  • Strong distribution network
  • High investment in research and development

Weaknesses

  • Decreasing revenue
  • High dependence on the US market for revenue generation

Opportunities

  • Expanding into other economies
  • Launching new products related to the market

Threats

  • Stringent government regulations

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateApproachDevelopment
July 2016AgreementSecond Sight signed two exclusive distribution agreements with Orient Europharma Co., Ltd, Taiwan and Arshia Gostar Darman Co., Ltd, Iran for the distribution of the Argus II Retinal Prosthesis System in Iran and Taiwan.
February 2016AgreementSecond Sight signed an agreement with Tecnosalud S.A. for the distribution of Argus II Retinal Prosthesis System in Argentina.

Product Offering

  • SECOND SIGHT
    • Artificial Retina

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 4 Mn in 2016 to USD 6.9 Mn in 2018.
SECOND SIGHT — By Business Segment
Series (USD Mn)201620172018
Sales486.9

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.

Get Contacts →